Although the revenue and EPS for Teleflex (TFX) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Teleflex (TFX) came out with quarterly earnings of $3.49 per share, beating the Zacks Consensus Estimate of $3.38 per share. This compares to earnings of $3.64 per share a year ago.
Surgical equipment maker Teleflex reported a better-than-expected profit for the third quarter on Thursday, helped by strong demand for its medical devices.
Teleflex launches the next-generation Arrow VPS Rhythm DLX Device and NaviCurve Stylet in Canada.
Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investors with an interest in Medical - Instruments stocks have likely encountered both Teleflex (TFX) and Edwards Lifesciences (EW). But which of these two companies is the best option for those looking for undervalued stocks?
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Edwards Lifesciences (EW). But which of these two companies is the best option for those looking for undervalued stocks?
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their buck right now?
TFX instils optimism with its robust performance in the Interventional category and potential in Asia.
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks offers value investors a better bang for their buck right now?
Teleflex (TFX) publishes an analysis of clinical data showcasing the Titan SGS Stapler's enhanced clinical outcomes and significant efficiency benefits.
Investors looking for stocks in the Medical - Instruments sector might want to consider either Teleflex (TFX) or Edwards Lifesciences (EW). But which of these two companies is the best option for those looking for undervalued stocks?